Deletion, mutation, and loss of expression of KLF6 in human prostate cancer

Autor: Robert L. Vessella, Ceshi Chen, Xiaodong Sun, Heikki Helin, Jin-Tang Dong, E. Hyytinen, Henry F. Frierson, Pasi A. Koivisto
Rok vydání: 2003
Předmět:
Male
Tumor suppressor gene
Transplantation
Heterologous

Kruppel-Like Transcription Factors
Loss of Heterozygosity
Biology
Severe Acute Respiratory Syndrome
medicine.disease_cause
Pathology and Forensic Medicine
Loss of heterozygosity
Prostate cancer
Mice
Prostate
Proto-Oncogene Proteins
medicine
Kruppel-Like Factor 6
Tumor Cells
Cultured

Animals
Humans
Genes
Tumor Suppressor

DNA Primers
Base Sequence
Reverse Transcriptase Polymerase Chain Reaction
Cancer
Prostatic Neoplasms
Zinc Fingers
Exons
medicine.disease
United States
DNA-Binding Proteins
Repressor Proteins
Gene Expression Regulation
Neoplastic

medicine.anatomical_structure
KLF6
Severe acute respiratory syndrome-related coronavirus
Mutation
Cancer research
Trans-Activators
Commentary
Adenocarcinoma
Carcinogenesis
5' Untranslated Regions
Cell Division
Gene Deletion
Regular Articles
Transcription Factors
Zdroj: The American journal of pathology. 162(4)
ISSN: 0002-9440
Popis: Kruppel-like factors (KLFs) are a group of transcription factors that appear to be involved in different biological processes including carcinogenesis. In a recent study, KLF6 was reported as a tumor suppressor gene in prostate cancer because of its frequent loss of heterozygosity (LOH) and mutation as well as functional suppression of cell proliferation. Loss of chromosomal locus spanning KLF6 is relatively infrequent in other published studies of prostate cancer, however. To clarify the role of KLF6 in prostate cancers, particularly those that are high grade, we examined KLF6 for deletion, mutation, and loss of expression in 96 prostate cancer samples including 21 xenografts/cell lines. Loss of heterozygosity occurred in 4 (19%) of 21 xenografts/cell lines and 8 (28%) of 29 informative tumors. Fourteen of the 96 (15%) samples showed 15 somatic sequence changes in the KLF6 gene, including 7 that changed KLF6 peptide sequences, 4 that did not, and 4 that were located in untranslated regions. Expression levels of KLF6 were significantly lost in 4 of 20 (20%) xenografts/cell lines of prostate cancer, as detected by RT-PCR and Northern blot analysis. These findings indicate that significant genetic alterations of KLF6 occur in a minority of high-grade prostate cancers.
Databáze: OpenAIRE